Imperva (IMPV) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Oppenheimer Remains Bullish on Imperva (IMPV) Following 1Q Beat
May 6, 2016 9:46 AM EDTOppenheimer maintained an Outperform rating on Imperva (NYSE: IMPV), and cut the price target to $60.00 (from $70.00), following the company's 1Q earnings report. Revenue came in at $59.8M, ahead of the consensus of $59.5M. EPS of $0.20, bested the Street's $0.28 estimate. 2Q16 revenues were guided... More
Needham & Company Downgrades Imperva (IMPV) to Hold
May 6, 2016 7:32 AM EDTNeedham & Company downgraded Imperva (NYSE: IMPV) from Buy to Hold.
Analyst Scott Zeller commented, "MarQ was in-line for Imperva on revenues and loss per share - surprising given the favorable security spending climate. In field discussions, we have heard IMPV has strong... More



